|
GTPBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.073600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.868200E-01 |
| Normal-vs-Stage2 |
2.085800E-01 |
| Normal-vs-Stage3 |
2.854400E-01 |
| Normal-vs-Stage4 |
9.630400E-01 |
| Stage1-vs-Stage2 |
2.912400E-01 |
| Stage1-vs-Stage3 |
4.891000E-01 |
| Stage1-vs-Stage4 |
6.572600E-01 |
| Stage2-vs-Stage3 |
6.063000E-01 |
| Stage2-vs-Stage4 |
2.405600E-01 |
| Stage3-vs-Stage4 |
3.592800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.056800E-01 |
| Normal-vs-AfricanAmerican |
4.966200E-01 |
| Normal-vs-Asian |
7.180200E-01 |
| Caucasian-vs-AfricanAmerican |
3.191200E-01 |
| Caucasian-vs-Asian |
8.998000E-01 |
| AfricanAmerican-vs-Asian |
3.682600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.873400E-01 |
| Normal-vs-Female |
3.950800E-01 |
| Male-vs-Female |
8.877800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.090600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.509400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.244300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.833800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.229000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.391610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.321600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.831440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.558400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.402600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.776800E-01 |
| Classical-VS-Follicular |
4.07079999709126E-08 |
| Classical-VS-Other |
9.914000E-02 |
| Classical-VS-Normal |
4.762400E-01 |
| Tall-VS-Follicular |
1.280640E-03 |
| Tall-VS-Other |
2.896200E-01 |
| Tall-VS-Normal |
9.997000E-01 |
| Follicular-VS-Other |
8.708600E-01 |
| Follicular-VS-Normal |
1.594020E-04 |
| Other-VS-Normal |
2.845000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.016800E-01 |
| Normal-vs-N1 |
2.743600E-01 |
| N0-vs-N1 |
9.636200E-01 |
|
|
